About DiabetOmics
DiabetOmics is a company based in Hillsboro (United States) founded in 2008.. DiabetOmics has raised $11 million across 6 funding rounds from investors including HHS, Ventureast and K I Varaprasad Reddy. The company has 35 employees as of October 31, 2024. DiabetOmics offers products and services including Lumella, Glucema, Insudex, and RAprime. DiabetOmics operates in a competitive market with competitors including SD Biosensor, 1Drop Diagnostics, Nova Biomedical, BioHermes and DxGen, among others.
- Headquarter Hillsboro, United States
- Employees 35 as on 31 Oct, 2024
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Diabetomics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$11 M (USD)
in 6 rounds
-
Latest Funding Round
$5 M (USD), Series C
Mar 12, 2015
-
Investors
HHS
& 4 more
-
Employee Count
35
as on Oct 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DiabetOmics
DiabetOmics offers a comprehensive portfolio of products and services, including Lumella, Glucema, Insudex, and RAprime. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Test for maternal health conditions like preeclampsia and gestational diabetes.
Quantitative test for diabetes types one and two detection.
Assists in monitoring therapeutic efficacy for targeted therapies.
Tool for rheumatoid arthritis and autoimmune disease identification.
Funding Insights of DiabetOmics
DiabetOmics has successfully raised a total of $11M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $5 million completed in March 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series C — $5.0M
-
First Round
First Round
(27 Apr 2010)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2015 | Amount | Series C - DiabetOmics | Valuation | Ventureast , K I Varaprasad Reddy |
|
| Nov, 2014 | Amount | Series B - DiabetOmics | Valuation | Rogue Venture Partners | |
| Sep, 2012 | Amount | Grant - DiabetOmics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in DiabetOmics
DiabetOmics has secured backing from 5 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include HHS, Ventureast and K I Varaprasad Reddy. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in technology, healthcare, and clean environment sectors since 1997.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
A private family foundation supporting community development in Wausau.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by DiabetOmics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - DiabetOmics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Diabetomics Comparisons
Competitors of DiabetOmics
DiabetOmics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SD Biosensor, 1Drop Diagnostics, Nova Biomedical, BioHermes and DxGen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biosensors for point-of-care diagnostics are developed by SD Biosensor.
|
|
| domain | founded_year | HQ Location |
Finger-prick point-of-care diagnostics are provided for biomarker testing.
|
|
| domain | founded_year | HQ Location |
Developer of advanced blood testing analyzers and meters. This company manufactures and sells a wide variety of analyzers for hospital, point-of-care, blood bank, biotechnology, veterinary, and sports medicine applications. Products include blood gas analyzers, glucose meters, lactate meters, and cell culture analyzers. They also offer contract development and manufacturing services for other medical device companies. The analyzers utilize various measurement technologies, including potentiometric, amperometric, and spectrophotometric methods. The company provides complete technical support and product information globally.
|
|
| domain | founded_year | HQ Location |
Provider of POC diagnostic devices and kits
|
|
| domain | founded_year | HQ Location |
Point-of-care diagnostic products for diabetes and tuberculosis are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Diabetomics
Frequently Asked Questions about DiabetOmics
When was DiabetOmics founded?
DiabetOmics was founded in 2008 and raised its 1st funding round 2 years after it was founded.
Where is DiabetOmics located?
DiabetOmics is headquartered in Hillsboro, United States. It is registered at Hillsboro, Oregon, United States.
Is DiabetOmics a funded company?
DiabetOmics is a funded company, having raised a total of $11M across 6 funding rounds to date. The company's 1st funding round was a Grant of $582.75K, raised on Apr 27, 2010.
How many employees does DiabetOmics have?
As of Oct 31, 2024, the latest employee count at DiabetOmics is 35.
What does DiabetOmics do?
Point-of-care risk assessment tests for diabetes and womens health disorders. Its diabetes diagnostic test includes a saliva based test that measures total saliva glycosylated protein levels to estimate recent average blood glucose levels. It also offers the Pregnancy Metabolic Profile to estimate the risk of preeclampsia and gestational diabetes in expectant mothers by measuring the level of glycosylated fibronectin in maternal blood. It is also developing point-of-care tests for specific biomarkers that estimate the risk of developing type 1 (juvenile) diabetes, and detection of autoimmune components suspected in type 2 diabetes.
Who are the top competitors of DiabetOmics?
DiabetOmics's top competitors include SD Biosensor, Nova Biomedical and MOMM Diagnostics.
What products or services does DiabetOmics offer?
DiabetOmics offers Lumella, Glucema, Insudex, and RAprime.
Who are DiabetOmics's investors?
DiabetOmics has 5 investors. Key investors include HHS, Ventureast, K I Varaprasad Reddy, Rogue Venture Partners, and Dudley Foundation.